World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN63952470
Date of registration: 27/07/2016
Prospective Registration: No
Primary sponsor: University Malaya Medical Centre, University of Malaya.
Public title: Comparing the impact of dienogest with short term gonadotropin-releasing hormone (GnRH) analogue usage in endometriosis prior to laparoscopic cystectomy.
Scientific title: Comparing the impact of DIenogest with short term GnRH analogue usage in women with Endometriosis prior to laparoscopic Cystectomy: a randomised controlled trial
Date of first enrolment: 01/06/2016
Target sample size: 120
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN63952470
Study type:  Interventional
Study design:  Interventional randomised controlled trial, single centre. (Treatment)  
Phase: 
Countries of recruitment
Malaysia
Contacts
Name: Aizura Syafinaz    Ahmad Adlan
Address:  104, SS22/2 Damansara Jaya 47400 Petaling Jaya Malaysia
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Patients with cyst suspicious of endometrioma
2. Cyst measures > 4 cm
3. Planned for a laparoscopic cystectomy

Exclusion criteria: Patients with cysts suspicious of malignancy.

Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Endometriosis
Urological and Genital Diseases
Intervention(s)
Prior to the initiation of the study, blood will be taken for series of investigations- for AMH, Ca 125, FSH/LH level. Transvaginal ultrasound will be performed to look for antral follicular count.

Participants are allocated into one of three groups:
Group 1: No pretreatment administered pre-operatively (control group)
Group 2: single dose of GnRH analogue will be given (s/c lucrin 3.75mg) 1 month prior to the surgery date
Group 3: oral dienogest 2mg daily will be given to be taken for 30 days

A laparoscopic cystectomy will be performed 1 month after the initiation of the above treatment. After the operation all participants are also assessed regarding overall satisfaction of the treatment that they have received.

Randomisation is made by computerised block randomisation. Patient will pick 1 out of 3 sealed envelope the patient is not blinded by the treatment that they will receive, the surgeon however will not be made aware of the treatment received by their patient.
Primary Outcome(s)
1. Feasibility of cyst extraction intraoperatively (rating: easy/moderate/difficult)
2. Duration of surgery (recorded in minutes)
2. Patient satisfaction with the post operative pain relief using a visual analogue score
Secondary Outcome(s)
Intraoperative blood loss in millilitres. Outcome will be retrieved from the surgical notes, anaesthetists notes on or after hospital discharge.
Secondary ID(s)
NMRR-16-317-29736
Source(s) of Monetary Support
University Malaya Medical Centre
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history